mefloquine
Selected indexed studies
- Mefloquine as a prophylaxis for malaria needs to be revisited. (Int J Parasitol Drugs Drug Resist, 2021) [PMID:34339933]
- Cellular targets of mefloquine. (Toxicology, 2021) [PMID:34678321]
- Review of the mechanism underlying mefloquine-induced neurotoxicity. (Crit Rev Toxicol, 2021) [PMID:33905310]
_Worker-drafted node — pending editorial review._
Connections
mefloquine is a side effect of
Sources
- Mefloquine as a prophylaxis for malaria needs to be revisited. (2021) pubmed
- Cellular targets of mefloquine. (2021) pubmed
- Review of the mechanism underlying mefloquine-induced neurotoxicity. (2021) pubmed
- Mefloquine. (1994) pubmed
- Mefloquine for malaria prophylaxis in military personnel. (2020) pubmed
- Mefloquine to prevent malaria: a systematic review of trials. (1997) pubmed
- Mefloquine-associated rhabdomyolysis. (2016) pubmed
- Clinical pharmacokinetics of mefloquine. (1990) pubmed
- Mefloquine for preventing malaria in non-immune adult travellers. (2000) pubmed
- Mefloquine. A review of its antimalarial activity, pharmacokinetic properties and therapeutic efficacy. (1993) pubmed